One of the most important lessons learned in Africa—and throughout the Covid-19 pandemic—is that data is your biggest ally. We need data to tell us what’s going wrong and why. But most importantly, we need this information in real time.
With analytics, faster, more informed decision-making is possible. This provides opportunities for healthcare leaders and organizations to find greater alignment on priorities, resources and outcomes.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
PierianDX has bought Tute Genomics, a move that underscores the trend toward providing an end-to-end solution in clinical genomics analysis to labs.
The new version seeks to make it affordable for organizations to evaluate and test the effectiveness of their own programs.
Flare Capital Partners and Greycroft Partners led the Series A with participation from strategic healthcare investors.
The Connectivity Bridge is designed to be used with a 3G signal and medical devices such as a blood glucose monitor.
The new white coat of anxiety is a phrase I use to describe the myriad concerns and changes taking place in health care today that are causing providers angst.
It also has plans to pilot its technology with some Blue Cross Blue Shield plans later this year.
